Healius Limited announced the appointment of CEO

Healius Limited (ASX: HLS) announces that its current CEO and Managing Director, Dr. Malcolm Parmenter is stepping down from his position and current CFO and COO Ms. Maxine Jaquet is appointed as new CEO of the company, it will be effective from 1 march 2023. Dr. Malcolm Parmenter has been CEO since September 2017. Ms Jaquet joined the company in 2015, has been CFO since August 2019, and CFO and COO since January 2021.

“In the near term, I am focused on accelerating the improvements in our underlying performance. Specifically, this means managing the transition from COVID-19 testing to our business-as-usual diagnostics with improved margins while also accelerating our growth opportunities especially in high-acuity disease and specialty diagnostics,” Ms Jaquet said.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com